Legend Biotech (LEGN) Cash from Financing Activities (2019 - 2026)
Legend Biotech's Cash from Financing Activities came in at $167.7 million for Q2 2026, compared with -$900,000 a year earlier.
Powered by 
Analysis
Legend Biotech (LEGN) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Legend Biotech reported Cash from Financing Activities of $166.55 million; for FY2025, it was -$300,000.
- Going back by year, Cash from Financing Activities was $5.7 million in FY2024 (-99.3%), $791.4 million in FY2023 (+109.4%), $377.98 million in FY2022 (-39.7%) and $626.66 million in FY2021 (+1.3%).
- The Q2 2026 figure represents the highest quarterly Cash from Financing Activities since Q2 2023.
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q3 2024 (growth of 341.7%), and the weakest in Q2 2024 (a decline of 99.9%).
- Business Quant data shows LEGN's Cash from Financing Activities at -$1.2 million (Q1 2026), -$600,000 (Q4 2025) and $647,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Legend Biotech | 3.67 Bn | -74.25 Mn | 251.50 Mn | 167.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 167.70 Mn |
| Mar 31, 2026 | -1.20 Mn |
| Dec 31, 2025 | -600,000.00 |
| Sep 30, 2025 | 647,000.00 |
| Jun 30, 2025 | -900,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | 4.25 Mn |
| Jun 30, 2024 | 955,000.00 |
| Mar 31, 2024 | 831,000.00 |
| Dec 31, 2023 | 925,000.00 |
| Sep 30, 2023 | 961,000.00 |
| Jun 30, 2023 | 790.05 Mn |
| Mar 31, 2023 | -444,000.00 |
| Dec 31, 2022 | -783,000.00 |
| Sep 30, 2022 | 377.73 Mn |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 25,000.00 |
| Dec 31, 2021 | 323.56 Mn |
| Sep 30, 2021 | 1.14 Mn |
API Access
Legend Biotech Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=LEGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "LEGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=LEGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();